Posfai D, Eubanks AL, Keim AI, et al. Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity. Antimicrob Agents Chemother. 2018;62(4). doi:10.1128/AAC.01799-17
Ogbunugafor B, Wylie S, Diakite I, Weinreich DM, Hartl DL. Adaptive Landscape by Environment Interactions Dictate Evolutionary Dynamics in Models of Drug Resistance. PLoS Comput Biol. 2016;12(1):e1004710. doi:10.1371/journal.pcbi.1004710
Obaldia N, Dow GS, Gerena L, et al. Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model. Sci Rep. 2016;6:21216. doi:10.1038/srep21216
Martyn DC, Cortese JF, Tyndall E, et al. Antiplasmodial activity of piperazine sulfonamides. Bioorg Med Chem Lett. 2010;20(1):218-21. doi:10.1016/j.bmcl.2009.10.130
Kato N, Comer E, Sakata-Kato T, et al. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature. 2016;538(7625):344-349. doi:10.1038/nature19804
Martyn DC, Nijjar A, Celatka CA, et al. Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines. Bioorg Med Chem Lett. 2010;20(1):228-31. doi:10.1016/j.bmcl.2009.10.133
Comer E, Beaudoin JA, Kato N, et al. Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents. J Med Chem. 2014;57(20):8496-502. doi:10.1021/jm500994n
Martyn DC, Beletsky G, Cortese JF, et al. Synthesis and in vitro DMPK profiling of a 1,2-dioxolane-based library with activity against Plasmodium falciparum. Bioorg Med Chem Lett. 2009;19(19):5657-60. doi:10.1016/j.bmcl.2009.08.024
Martyn DC, Ramirez AP, Beattie MJ, et al. Synthesis of spiro-1,2-dioxolanes and their activity against Plasmodium falciparum. Bioorg Med Chem Lett. 2008;18(24):6521-4. doi:10.1016/j.bmcl.2008.10.083
Dong CK, Urgaonkar S, Cortese JF, et al. Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors. Chem Biol. 2011;18(12):1602-10. doi:10.1016/j.chembiol.2011.09.016